In this issue:
- Equity of travel to access care
- Early prehabilitation in newly diagnosed LC
- Staging of LC to guide radiotherapy planning
- LC screening targeting Māori
- Survey of LC care across Australia and NZ
- Primary results from MARIPOSA-2
- Cardiovascular risks of immunotherapy
- Amivantamab ± lazertinib for EGFR-mutated NSCLC
- Final results from EUCROSS
- Entrectinib in NTRK fusion-positive NSCLC
Please login below to download this issue (PDF)